Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Conditions
- Hematopoietic Cell Transplantation Recipient
- Refractory B-Cell Non-Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Refractory T-Cell Non-Hodgkin Lymphoma
Interventions
- PROCEDURE: Allogeneic Bone Marrow Transplantation
- PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
- BIOLOGICAL: Anti-Thymocyte Globulin
- DRUG: Busulfan
- DRUG: Clofarabine
- DRUG: Gemcitabine Hydrochloride
- DRUG: Mycophenolate Mofetil
- PROCEDURE: Peripheral Blood Stem Cell Transplantation
- OTHER: Pharmacological Study
- BIOLOGICAL: Rituximab
- DRUG: Tacrolimus
Sponsor
M.D. Anderson Cancer Center
Collaborators